546 — Medtecs International Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Medtecs International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	C2021 December 31st	C2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	135	16.9	-30.7	-22.5	-23.4
Depreciation
Amortisation
Non-Cash Items	1.75	2.86	15.3	9.55	16.7
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-43.2	3.8	10.4	-1.32	1.69
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	102	30.1	1.26	-7.18	2.34
Capital Expenditures	-8.4	-16.4	-15.3	-7.41	-3.35
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	2.22	0.985	-13.9	17	0.628
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-6.18	-15.4	-29.2	9.61	-2.73
Financing Cash Flow Items	-1.43	1.64	-0.375	-5.29	0.279
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-16.3	-47.5	-3.02	1.84	-4.94
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	79.1	-33.1	-30.9	4.18	-5.52